Jennifer Schumann
Datos Biográficos
| ID | 3824153 |
|---|---|
| NOMBRE | Jennifer Schumann |
| NOMBRES | Jennifer |
| APELLIDO | Schumann |
| FIRMA | SCHUMANN J |
| AFILIACIONES | Victorian Institute of Forensic Medicine |
| ORCID | 0000-0002-8870-6272 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 14 |
| TOTAL DE CITAS | 5 |
| TOTAL COMO AUTOR | 14 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2019 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 1 |
Identification of nitazene‐related deaths in Australia
Data sharing is not applicable to this article as no new data were created or analyzed in this study
Emerging Risks of Nitazene‐Adulterated Vapes in Australia
J.M. receives funding from the Department of Home Affairs for research into the Australian illicit nicotine market. J.M. also has an unpaid role as Tobacco Harm Reduction Advisor to the board of the non-profit organisation Harm Reduction Australia. This arrangement creates no obligations and in no way compromises the independence of J.M. J.L.S. has no conflicts to declare. Data sharing not applicable to this article as no datasets were generated …
The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction—A Narrative Review
Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Novel benzodiazepines in illicit drug use
BACKGROUND: Novel or unregulated benzodiazepines are increasingly detected in illicit drug markets and may be perceived to pose greater clinical risk than regulated pharmaceutical benzodiazepines. However, much of the evidence underpinning these concerns derives from case reports, surveillance data, and settings characterised by extensive polysubstance exposure. We examined whether detection of novel/unregulated benzodiazepines is associated with…
Changes over time in novel benzodiazepines contributing to fatal overdoses in Victoria, Australia
Novel psychoactive substances in Australian emergency departments
Drug intelligence data generated in an acute harm setting such as the ED can provide early warning of drugs of concern circulating in the community, including NPS. This facilitates rapid community responses to reduce harm and inform subsequent public health responses
Novel harm reduction measures at music festivals in Australia
Drug-related deaths at Australian music festivals
The findings suggest that drug-related deaths at music festivals in Australia typically involve young people using multiple illicit substances in combination with alcohol. Most are unintentional and could potentially be prevented through the implementation of a range of harm reduction strategies, including mobile medical care, drug checking services, and increased consumer education and awareness
What are the research priorities for optimising the safe and effective use of opioids in Australian general practice
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia
A risk-based approach to community illicit drug toxicosurveillance
What makes a straw man acceptable? Three experiments assessing linguistic factors
What makes a straw man acceptable? Three experiments assessing linguistic factors
What are the research priorities for optimising the safe and effective use of opioids in Australian general practice
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia
A risk-based approach to community illicit drug toxicosurveillance
Novel harm reduction measures at music festivals in Australia
Drug-related deaths at Australian music festivals
The findings suggest that drug-related deaths at music festivals in Australia typically involve young people using multiple illicit substances in combination with alcohol. Most are unintentional and could potentially be prevented through the implementation of a range of harm reduction strategies, including mobile medical care, drug checking services, and increased consumer education and awareness
Changes over time in novel benzodiazepines contributing to fatal overdoses in Victoria, Australia
Novel psychoactive substances in Australian emergency departments
Drug intelligence data generated in an acute harm setting such as the ED can provide early warning of drugs of concern circulating in the community, including NPS. This facilitates rapid community responses to reduce harm and inform subsequent public health responses
Identification of nitazene‐related deaths in Australia
Data sharing is not applicable to this article as no new data were created or analyzed in this study
Emerging Risks of Nitazene‐Adulterated Vapes in Australia
J.M. receives funding from the Department of Home Affairs for research into the Australian illicit nicotine market. J.M. also has an unpaid role as Tobacco Harm Reduction Advisor to the board of the non-profit organisation Harm Reduction Australia. This arrangement creates no obligations and in no way compromises the independence of J.M. J.L.S. has no conflicts to declare. Data sharing not applicable to this article as no datasets were generated …
The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction—A Narrative Review
Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Novel benzodiazepines in illicit drug use
BACKGROUND: Novel or unregulated benzodiazepines are increasingly detected in illicit drug markets and may be perceived to pose greater clinical risk than regulated pharmaceutical benzodiazepines. However, much of the evidence underpinning these concerns derives from case reports, surveillance data, and settings characterised by extensive polysubstance exposure. We examined whether detection of novel/unregulated benzodiazepines is associated with…
Forensic Toxicology and Drug Analysis (10 obras) · Medicine (9 obras) · Harm reduction (6 obras) · Psychology (6 obras) · Public health (6 obras) · Medical emergency (5 obras) · Nursing (5 obras) · Opioid Use Disorder Treatment (5 obras) · Psychiatry (5 obras) · Drug (4 obras)